Next Article in Journal
Pharmacy Practice and Education in Slovenia
Next Article in Special Issue
Rare and Imported Infections: Are We Prepared?
Previous Article in Journal
Evaluating the Effectiveness of Clinical Pharmacy Consultations on Nutrition, Physical Activity, and Sleep in Improving Patient-Reported Psychiatric Outcomes for Individuals with Mental Illnesses
Previous Article in Special Issue
Teicoplanin-Induced Anaphylactic Reaction in Children: A Case Report
Open AccessReview

Risk of Transverse Myelitis Following Dengue Infection: A Systematic Review of the Literature

1
School of Medicine, Imperial College London, London SW7 2AZ, UK
2
Department of Family Medicine, University of Benin Teaching Hospital (UBTH), Benin City, Nigeria
3
Department of Medicine, Queen’s Hospital, Romford RM7 0AG, UK
4
Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George’s, University of London, London SW17 0RE, UK
*
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(1), 3; https://doi.org/10.3390/pharmacy7010003
Received: 17 November 2018 / Revised: 10 December 2018 / Accepted: 19 December 2018 / Published: 23 December 2018
(This article belongs to the Special Issue Rare and Imported Paediatric Infections)
Introduction: Dengue virus (DENV) is one of the most common arbovirus diseases, with a wide spectrum of presentation. Spinal cord involvement in dengue infection (DF) is rare. However, the risk of transverse myelitis (TM) following Dengue has not been systematically assessed. Methods: We undertook a systematic review of published English literature from January 1974 to December 2017 to assess risk of TM and outcomes following DF. Data sources included EMBASE, MEDLINE, Cochrane library, ISI web of knowledge, conference proceedings and references within identified articles. Results: We identified 242 potential studies, 62 were duplicates. A further 136 were excluded on the basis of title and abstract and 19 studies did not meet the eligibility criteria on full text screening. We included 25 publications involving 2672 cases of DF. A small proportion (10.8%, (289/2672)) had neurological complications, of which 2.3% (61/2672) was TM. For articles reporting epidemiological data, the neurological complication was twice in males compared to female 67.7% (130/192) vs. 32.7% (62/192) and 1.5-fold increase TM for males 59.3% (32/54) vs 40.7% (22/54). The mean age at presentation was 33.1years (range 0.75–61), with onset at 11.7days. The method of diagnosing TM due to DF was mainly IgM seropositivity 92% (n = 23/25) and the commonest treatment modality was steroid 78.3% (n = 18/23). Only half had full recovery 50.8% (n = 31/61). There was no mortality following dengue, however, the crude case fatality rate following TM was 3.3% (n = 2/61). Conclusion: This review highlights the risk of TM following dengue. Although neurological complications are rare, especially TM, once set in, it is associated with a significant morbidity. View Full-Text
Keywords: Dengue Fever; transverse myelitis; risk; systematic review Dengue Fever; transverse myelitis; risk; systematic review
Show Figures

Figure 1

MDPI and ACS Style

Badat, N.; Abdulhussein, D.; Oligbu, P.; Ojubolamo, O.; Oligbu, G. Risk of Transverse Myelitis Following Dengue Infection: A Systematic Review of the Literature. Pharmacy 2019, 7, 3.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop